In cancer-stimulating MDSCs, we have recently shown that activation of PPARγ by ligand treatment inhibited lal−/− MDSCs stimulation of tumor cell growth and invasion in vivo, and tumor cell proliferation and migration in vitro through correction of lal−/− MDSCs transendothelial migration, and differentiation from bone marrow Lin− cells. Here, PPARG is linked to cancer.